Medifast, Inc. MED

Set alert

Price alert · MED

All alert types
12.70 USD +0.17 +1.39%

As of Nov 3, 1:34 PM ET

Bid
12.67 × 100
Ask
12.76 × 500
12.51 Day range 12.85
9.22 52-week range 13.45
YTD
+18.95%
1 year
+6.94%
Open
12.61
Prev close
12.53
Mkt cap
141.80M
Vol
34.41K
Avg vol
141.18K
EPS
-3.70
P/E
0.00
Div yield
0.00%
More statistics
Low
12.51
High
12.85
Forward P/E
56.17
Beta
1.16
Short ratio
7.68
Inst. own
86.16%
Dividend
6.60
Ex-div date
Sep 17, 2023
50-d avg
18.72
200-d avg
22.71
1y target
16.50

MAX chart

Chart tools
Interval

Events in this range
  • Feb 7, 2023Dividend: 1.64
  • Aug 7, 2023Earnings: 2.77; estimate 1.44; surprise 92.36%
  • Nov 6, 2023Earnings: 2.12; estimate 1.02; surprise 107.84%
  • Jun 5, 2024Downgrade: DA Davidson · Neutral → Underperform
  • Aug 5, 2024Earnings: 0.92; estimate 0.36; surprise 155.56%
  • Nov 4, 2024Earnings: 0.35; estimate -0.15; surprise 333.33%
  • Nov 5, 2024Rating: DA Davidson · Underperform → Neutral
Signals (110)
NameDateAgo
SMA: BullishAug 1, 20263 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 1, 20266 months ago
MACD: Buy SignalNov 1, 20242 years ago
RSI: OversoldFeb 1, 20242 years ago
SMA: BearishMar 1, 20224 years ago
MACD: Sell SignalOct 1, 20215 years ago
SMA: BearishAug 1, 20215 years ago
RSI: OverboughtMay 1, 20215 years ago
RSI: OverboughtFeb 1, 20215 years ago
MACD: Buy SignalJul 1, 20206 years ago
SMA: BullishJun 1, 20206 years ago
SMA: BullishMay 1, 20206 years ago
SMA: BearishAug 1, 20197 years ago
MACD: Sell SignalJan 1, 20197 years ago
SMA: BearishNov 1, 20188 years ago
RSI: OverboughtAug 1, 20179 years ago
SMA: BullishJul 1, 20179 years ago
SMA: BearishJun 1, 20179 years ago
RSI: OverboughtJan 1, 20179 years ago

Newest 20 of 110.

Analyst view

Price target (mean) 16.50 +29.9% upside
Target (low)
16.00
Target (mean)
16.50
Target (high)
17.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2
  • 2 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MED analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.16-0.22 – -0.101.09-114.7%114.25M-40.2%2
Next quarter-0.19-0.32 – -0.060.66-128.8%130.75M-25.2%2
Current year1.771.71 – 1.839.64-81.6%597.70M-44.3%2
Next year0.300.19 – 0.411.77-83.0%509.85M-14.7%2

Upgrades and downgrades

The latest rating changes

MED analyst upgrades and downgrades
DateFirmActionFromTo
Nov 5, 2024DA DavidsonUpgradeUnderperformNeutral
Jul 22, 2024DA DavidsonMaintainedUnderperformUnderperform
Jun 5, 2024DA DavidsonDowngradeNeutralUnderperform
Apr 30, 2024DA DavidsonMaintainedNeutralNeutral
Feb 21, 2024DA DavidsonMaintainedNeutralNeutral
Oct 13, 2023Stephens & Co.Initiated—Equal-Weight
Aug 8, 2023DA DavidsonMaintainedNeutralNeutral
Jul 31, 2023DA DavidsonMaintainedNeutralNeutral
May 2, 2023DA DavidsonMaintained—Neutral
Feb 22, 2023DA DavidsonMaintained—Neutral
Nov 4, 2022DA DavidsonDowngradeBuyNeutral
Aug 4, 2022DA DavidsonMaintained—Buy
Aug 4, 2022JefferiesDowngradeBuyHold
Jun 2, 2022DA DavidsonMaintained—Buy
Feb 24, 2022DA DavidsonMaintained—Buy
Nov 8, 2021DA DavidsonMaintained—Buy
May 5, 2021DA DavidsonMaintained—Buy
Feb 26, 2021DA DavidsonMaintained—Buy
Jan 25, 2021JefferiesUpgradeHoldBuy
Jan 12, 2021DA DavidsonMaintained—Buy
Nov 5, 2020DA DavidsonUpgradeNeutralBuy
Jun 25, 2020B. Riley SecuritiesInitiated—Buy
May 6, 2020DA DavidsonMaintained—Neutral
Feb 27, 2020DA DavidsonMaintained—Neutral
Nov 8, 2019DA DavidsonDowngradeBuyNeutral
Jul 25, 2019JefferiesInitiated—Buy
Feb 27, 2019Sidoti & Co.MaintainedBuyBuy
Nov 8, 2018Sidoti & Co.UpgradeNeutralBuy
May 24, 2018DA DavidsonMaintainedBuyBuy
Apr 19, 2018Sidoti & Co.DowngradeBuyNeutral